HTGC

Business Context and Reporting Period

Company: Hercules Technology Growth Capital, Inc. (HTGC)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2005
Business Model: HTGC is an internally-managed, non-diversified closed-end investment company regulated as a Business Development Company (BDC). It provides debt and equity growth capital, primarily structured mezzanine debt, to technology-related and life sciences companies at various stages of development. The company intends to elect Regulated Investment Company (RIC) status effective January 1, 2006, though qualification is not yet certain.

Key Financial Metrics

Material Changes vs. Prior Period

• Portfolio Expansion: The investment portfolio grew from $16.7 million to $176.7 million, driven by $175.3 million in new debt originations and $3.5 million in equity investments during 2005.
• Capital Raising: The company completed an Initial Public Offering (IPO) in June 2005, raising approximately $70.9 million in net proceeds. Additionally, warrant exercises in early 2005 generated $12.4 million.
• Leverage: Total debt increased significantly to $76.0 million, comprised of a $25.0 million bridge loan and $51.0 million drawn under a new $100 million securitized credit facility with Citigroup.
• Profitability: The company transitioned from a net loss of $2.0 million in 2004 to a net income of $2.1 million in 2005, primarily due to increased investment income and realized/unrealized gains.
• Operating Expenses: Expenses rose to $9.1 million from $2.3 million, reflecting increased interest expense ($1.8 million), compensation ($3.7 million), and general administrative costs associated with public company status.

Guidance, Outlook, and Risks

Outlook and Strategy: HTGC plans to continue funding investment activities through a combination of debt and equity capital. The company intends to distribute quarterly dividends if it qualifies as a RIC. Management expects to utilize the full borrowing capacity of its Citigroup facility as new loans are originated. A rights offering for approximately 3.3 million shares was filed in January 2006 to raise an estimated $34 million.

Key Risks and Contingencies:

• RIC Qualification: There is no assurance the company will qualify as a RIC in 2006. Failure to qualify would subject the company to corporate-level income taxes, potentially reducing net assets and distributions.
• Liquidity and Leverage: The company relies on borrowings to leverage equity. If asset coverage ratios fall below 200%, the company may be restricted from issuing senior securities or making distributions. The Citigroup facility expires in July 2006 unless extended.
• Portfolio Valuation: Approximately 91% of assets are investments in private companies valued at fair value by the Board. These valuations are subjective and may differ from realized values.
• Concentration Risk: The portfolio is concentrated in technology and life sciences sectors. The ten largest customers represented 58.7% of the total fair value of investments.
• Interest Rate Risk: Borrowing costs are variable (LIBOR-based), while many portfolio loans are fixed-rate, creating potential margin compression in a rising rate environment.

Investor Verification Checklist

• RIC Status Confirmation: Verify if the company successfully elected RIC status for the 2006 tax year to avoid corporate-level taxation.
• Debt Facility Renewal: Confirm the extension or refinancing of the Citigroup securitized credit facility, which was set to expire in July 2006.
• Portfolio Performance: Monitor the realization of gains on equity warrants and the credit quality of the loan portfolio, specifically the $3.3 million write-down noted in a single portfolio company.
• Dividend Sustainability: Assess whether cash flow from operations and interest income is sufficient to support the declared dividend policy without eroding capital.
• Capital Deployment: Track the deployment of the $30.2 million in unfunded commitments and the proceeds from the pending rights offering.